Biomarkers in Gastrointestinal Cancer: Expert Perspectives and Guidance for Individualized Treatment

Get expert recommendations on using biomarker testing to individualize treatment for patients with gastrointestinal malignancies with an on-demand webcast downloadable slideset and expert commentary.

Share

Program Content

Activities

Tumor-Agnostic/CRC Biomarkers
Tumor-Agnostic Biomarkers and Targeted Treatment of Advanced Colorectal Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2022

Expires: June 02, 2023

Gastroesophageal Biomarkers
Targeted Treatment of Gastric, Esophageal, and Gastroesophageal Junction Cancers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2022

Expires: June 02, 2023

Panc/BTC Biomarkers
Targeted Treatment of Pancreatic and Hepatobiliary Cancers
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 03, 2022

Expires: June 02, 2023

No activities added yet

Activities

FAQ: GI Biomarkers
Biomarker Testing and Novel Targeted Agents in the Management of Gastrointestinal Cancers: Experts Address FAQs
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 22, 2022

Expires: August 21, 2023

Faculty

cover img faculity

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

cover img faculity

Michael J. Pishvaian, MD, PhD

Associate Professor
Sidney Kimmel Cancer Center
Johns Hopkins University
Director
Clinical Research, GI and Phase I Oncology in the National Capital Region
Johns Hopkins at Sibley Memorial Cancer Center
Washington, DC

cover img faculity

Manish A. Shah, MD

Assistant Member, Department of Medicine, Gastrointestinal Oncology
Memorial Sloan-Kettering Cancer Center
Attending Physician, Department of Medicine, Division of Solidy Tumor Oncology
Memorial Hospital
New York, New York

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Bayer Healthcare Pharma

Daiichi Sankyo, Inc.

Seagen Inc.

Turning Point Therapeutics Inc